Details for New Drug Application (NDA): 213474
✉ Email this page to a colleague
The generic ingredient in DOXEPIN HYDROCHLORIDE is doxepin hydrochloride. There are seven drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the doxepin hydrochloride profile page.
Summary for 213474
Tradename: | DOXEPIN HYDROCHLORIDE |
Applicant: | Contract Pharmacal |
Ingredient: | doxepin hydrochloride |
Patents: | 0 |
Suppliers and Packaging for NDA: 213474
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 213474 | ANDA | Contract Pharmacal Corp. | 10267-5059 | 10267-5059-4 | 1000 CAPSULE in 1 BOTTLE (10267-5059-4) |
DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 213474 | ANDA | Contract Pharmacal Corp. | 10267-5059 | 10267-5059-9 | 90 CAPSULE in 1 BOTTLE (10267-5059-9) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Jul 28, 2020 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Jul 28, 2020 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 50MG BASE | ||||
Approval Date: | Jul 28, 2020 | TE: | AB | RLD: | No |
Complete Access Available with Subscription